期刊
CURRENT MEDICINAL CHEMISTRY
卷 29, 期 23, 页码 4113-4135出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867329666220105120722
关键词
Cyclobutyl drugs; platinum; anticancer drugs; cancer; structure-activity relationship; approved drugs; kinase inhibitor
资金
- Science and Technology Program of Zhejiang Province (Key Innovative Team) [2018R01015]
- National Natural Science Foundation of China [21877101]
- Zhejiang Provincial Natural Science Foundation of China [LY19B020008]
- New-shoot Talents Program of Zhejiang Province [2021R403044]
- National Undergraduate Training Program for Innovation and Entrepreneurship of China [202010337039]
Cyclobutyl has become increasingly influential in drug design, serving as both a useful intermediate for synthesizing biomedical candidate materials and an indispensable framework for drug design and application. Platinum-based anticancer drugs containing cyclobutyl fragments have achieved remarkable success, bringing hope for the development of more cyclobutyl drugs.
In recent years, cyclobutyl has become more influential in the field of drug design. Its unique four-membered ring structure is not only a useful intermediate for the synthesis of biomedical candidate materials but also an indispensable framework for drug design and application. According to the therapeutic field, cyclobutyl drugs are roughly divided into tumor and cancer drugs, nervous system drugs, analgesics, antiviral drugs, and gastrointestinal drugs. Among them, platinum-based anticancer drugs containing cyclobutyl fragments have achieved remarkable success in the treatment of cancer, bringing new hope for the development of more cyclobutyl drugs. This article provides details of the research progress of the structure types, structure-activity relationships, targets, and mechanisms of cyclobutyl drugs that have been on the market or are in the clinical stage and provides ideas for the discovery and synthesis of novel cyclobutyl-containing drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据